The company C8 MediSensors, based in California (USA), has announced that it has obtained approval to market in Europe a new optical system-CE Mark-, which will allow diabetes patients to control their levels of glucose, in a comfortable and painless way, avoiding having to insert a needle under the skin, as is now done with traditional glucose monitoring devices.
The new continuous non-invasive glucose monitor (nCGM) uses the power of a beam of light that illuminates the patient's skin - using Raman spectroscopy - and causes the vibration of the glucose molecules, which allows measuring the level of this substance in the blood.
The data obtained is recorded in a small portable monitor that is placed under the clothes. In addition, readings of stored glucose levels are transferred to users' mobile phones, which makes it easier for these patients to be continually informed about their glucose levels and to act accordingly.
This new device will allow diabetics to maintain blood glucose levels as normalized as possible, which will have very positive consequences for their health. And is that according to the study 'Diabetes Control and Complications Trial (DCCT)', patients suffering from type 1 diabetes and who control glucose properly significantly reduce the risk of developing complications associated with the disease.
Specifically, and according to data from this study, the chances of suffering an ocular pathology are reduced by 76%, kidney affections by 50%, and neuronal disorders by 60%. Other studies have corroborated the importance of continuous glucose monitoring to reduce the appearance of complications, both in the case of type 1 and type 2 diabetes, and that the risk of hypoglycaemia is also reduced.
Clinical trials have shown that the accuracy of the C8 MediSensors optical glucose monitoring system is similar to that of invasive CGMs, but it is more comfortable, has a lower risk of infection, and is not painful. The new device, however, should not be used during pregnancy or in children under 18 years of age, or in those who have a very light or very dark skin tone, suffer peripheral vascular disease or are smokers.
More information: C8 MediSensors, Inc. (see www.c8medisensors.com)